Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 169

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Influence of disease‐modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: Results from a large observational inception study

Bukhari, M. A. S., Wiles, N. J., Lunt, M., Harrison, B. J., Scott, D. G. I., Symmons, D. P. M., Silman, A. J.·2003·Arthritis & Rheumatism

Abstract

Objective: To determine the effect of early treatment with disease‐modifying antirheumatic drugs (DMARDs) in reducing radiographic progression over a 5‐year period in patients with new‐onset inflammatory polyarthritis. Methods: Three hundred thirty‐five consecutive patients with paired radiographs obtained 1 year and 5 years after enrollment in a population‐based arthritis register were studied. Logistic regression was used to model differences in baseline factors associated with the start of DMARDs. The time from symptom onset to first use of DMARDs was stratified to represent 4 groups: no DMARD use, <6 months, 6–12 months, and >12 months. Radiographs of the hands and feet were scored using the Larsen method. Progression in the Larsen score was evaluated as a 5‐year score adjusted for the first film score. Negative binomial regression was used to compare Larsen score progression for each of the 3 treatment groups with that for patients not receiving DMARDs. Results were then adjusted for severity, based on propensity modeling. Results: Patients who received treatment had more radiographic progression than did patients who were untreated. Coefficients (95% confidence intervals), expressed as a multiple of the Larsen score in DMARD‐treated patients compared with untreated patients, were as follows: 1.6 (1.1–2.3) for <6 months, 2.4 (1.5–3.6) for 6–12 months, and 2.0 (1.4–2.8) for >12 months. As expected, patients receiving treatment had more severe disease at baseline. Using the propensity score as a method of adjusting for disease severity, the influence of treatment on outcome became attenuated as follows: 1.1 (0.8–1.7) for <6 months, 1.6 (1.0–2.6) for 6–12 months, and 1.5 (1.0–2.2) for >12 months. This effect was also seen in the crude Larsen score at year 5. Conclusion: In this observational study, DMARD treatment was a marker not only of worse disease at presentation but also of the radiographic state and radiographic progression at 5 years. After adjustments were made for baseline disease severity, earlier therapy was shown to have a beneficial effect on outcome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.10727

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 169

Metadata

Authors
Bukhari, M. A. S., Wiles, N. J., Lunt, M., Harrison, B. J., Scott, D. G. I., Symmons, D. P. M., & Silman, A. J.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2003-01
Volume
48
Issue
1
Pages
46-53
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2059468409
Cited by
169
References
2
FWCI
9.59
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Influence of disease‐modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: Results from a large observational inception study. https://app.cochat.ai/papers/10.1002/art.10727
The paper
Bukhari, M. A. S., Wiles, N. J., Lunt, M., Harrison, B. J., Scott, D. G. I., Symmons, D. P. M., & Silman, A. J. (2003). Influence of disease‐modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: Results from a large observational inception study. Arthritis & Rheumatism. https://doi.org/10.1002/art.10727

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.